Drugs for Obesity, A Review of Semaglutide and Tirzepatide
Penn Primary Care Podcast
English - January 18, 2024 07:00 - 92.7 MB - ★★★★★ - 49 ratingsHealth & Fitness penn primary care clinical kendal williams medicine Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Back Pain, Part 1. Review of Pathology and Surgical Treatment.
Next Episode: Update on Melanoma
In this podcast, Dr Williams speaks with Dr Anastassia Amaro, director of the Obesity and Metabolic Center at Penn, about the new drugs for obesity. The discussion starts with the physiology and pharmacology of both semaglutide and tirzepatide, and then covers the practical aspects of prescribing these drugs to patients.